Hicham Drissi

Hicham Drissi

Auto-generated profile, based on publicly available information

Hicham Drissi

Department of Orthopaedic Surgery, UConn Musculoskeletal Institute, UConn Stem Cell Institute, UConn Health, University of Connecticut, Farmington, Connecticut, USA

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 September 2012 in Journal of Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
RGRosa M. Guzzo
Rosa M. Guzzo
JGJason Gibson
Jason Gibson
RXRen‐He Xu
Ren‐He Xu
FLFrancis Y. Lee
Francis Y. Lee
HDHicham Drissi
Hicham Drissi

1 August 2010 in Molecular Endocrinology
Verified
Journal Article
Open access
PDF file
Elizabeth W. BradleyElizabeth W. Bradley
Elizabeth W. Bradley
MDM. Hicham Drissi
M. Hicham Drissi
Although genetic evidence demonstrated a requirement for Wnt5a during cartilage development, little is known about the mechanisms underlying Wnt5a-regulated chondrocyte growth and differentiation. We therefore investigated the signaling pathways by which Wnt5a influences chondrogenesis and differentiation to hypertrophy. Wnt5a treatment of chondroprogenitor cells increased chondrocyte hypertrophy and was associated with an increase in nuclear factor of activated T cells (NFAT) and a decrease in nuclear factor-κB (NF-κB) activation. In contrast, Wnt5a inhibited chondrocyte hypertrophy. This inhibition of hypertrophy occurred with the reciprocal signaling activation, in that a decrease in NFAT and an increase in NF-κB activation was observed. Furthermore, the increase in chondroprogenitor cell differentiation with Wnt5a treatment was blocked by calmodulin kinase or NFAT loss of function. In addition, the repression of chondrocyte hypertrophy observed was abrogated by NF-κB loss of function. Activation of the NFAT pathway downstream of Wnt5a also negatively regulated NF-κB activity, providing evidence of antagonism between these two pathways. Mechanistically, Wnt5a acts to increase chondrocyte differentiation at an early stage through calmodulin kinase /NFAT-dependent induction of Sox9. Conversely, Wnt5a represses chondrocyte hypertrophy via NF-κB-dependent inhibition of Runx2 expression. These data indicate that Wnt5a regulates chondrogenesis and chondrocyte hypertrophy in a stage-dependent manner through differential utilization of NFAT- and NF-κB-dependent signal transduction.

21 August 2008 in Journal of Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
LKLee A. Kaback
Lee A. Kaback
DSDo Y. Soung
Do Y. Soung
ANAmish Naik
Amish Naik
GGGraziello Geneau
Graziello Geneau
ESEdward M. Schwarz
Edward M. Schwarz
HDHicham Drissi
Hicham Drissi

19 March 2012 in Journal of Bone and Mineral Research
Verified
Journal Article
Open access
PDF file
DSDo Y Soung
Do Y Soung
LTLaleh Talebian
Laleh Talebian
CMChristina J Matheny
Christina J Matheny
RGRosa Guzzo
Rosa Guzzo
MSMaren E Speck
Maren E Speck
HDHicham Drissi
Hicham Drissi
Runx1 is expressed in skeletal elements, but its role in fracture repair has not been analyzed. We created mice with a hypomorphic Runx1 allele (Runx1L148A) and generated Runx1L148A/− mice in which >50% of Runx1 activity was abrogated. Runx1L148A/− mice were viable but runted. Their growth plates had extended proliferating and hypertrophic zones, and the percentages of Sox9‐, Runx2‐, and Runx3‐positive cells were decreased. Femoral fracture experiments revealed delayed cartilaginous callus formation, and the expression of chondrogenic markers was decreased. Conditional ablation of Runx1 in the mesenchymal progenitor cells of the limb with Prx1‐Cre conferred no obvious limb phenotype; however, cartilaginous callus formation was delayed following fracture. Embryonic limb bud–derived mesenchymal cells showed delayed chondrogenesis when the Runx1 allele was deleted ex vivo with adenoviral‐expressed Cre. Collectively, our data suggest that Runx1 is required for commitment and differentiation of chondroprogenitor cells into the chondrogenic lineage. © 2012 American Society for Bone and Mineral Research.

10 November 2010 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
Elizabeth W. BradleyElizabeth W. Bradley
Elizabeth W. Bradley
MDM. Hicham Drissi
M. Hicham Drissi

28 January 2008 in Oncogene
Verified
Journal Article
Open access
PDF file
RER A Eliseev
R A Eliseev
YDY-F Dong
Y-F Dong
ESE Sampson
E Sampson
MZMichael J Zuscik
Michael J Zuscik
ESE M Schwarz
E M Schwarz
MDM H Drissi
M H Drissi
The Runx family of transcription factors regulate cell growth and differentiation, and control the expression of target genes involved in cell fate decisions. We examined the role of the bone-related member of this family, Runx2, in regulating apoptosis via modulation of the Bcl2 family of genes in the osteosarcoma cell line Saos2. Our data demonstrate that Runx2 directly binds to two Runx-specific regulatory elements on the human bax promoter thereby inducing Bax expression. Furthermore, bone morphogenetic protein-induced or vector-mediated expression of Runx2 resulted in upregulation of Bax expression, and subsequent increased sensitivity of Saos2 cells to apoptosis. Finally, the observed upregulation of Bax expression and increased apoptosis were Runx2 dependent as Runx2 loss of function abrogated these effects. Our study provides the first evidence for Bax as a direct target of Runx2, suggesting that Runx2 may act as a proapoptotic factor in osteosarcoma cells.